COPY
Price
$16.09
Change
+$0.33 (+2.10%)
Updated
Nov 4, 03:10 PM (EDT)
Net Assets
433.12M
Intraday BUY SELL Signals
GM
Price
$92.42
Change
+$4.08 (+4.62%)
Updated
Nov 4, 04:59 PM (EDT)
Capitalization
77.51B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COPY vs GM

COPY vs GM Comparison Chart in %
View a ticker or compare two or three
VS
COPY vs. GM commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COPY is a Buy and GM is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COPY with price predictions
Nov 03, 2026

COPY's RSI Oscillator ascends from oversold territory

The RSI Indicator for COPY moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 6 similar instances when the indicator left oversold territory. In 6 of the 6 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on COPY as a result. In 26 of 26 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for COPY just turned positive on October 13, 2026. Looking at past instances where COPY's MACD turned positive, the stock continued to rise in 17 of 20 cases over the following month. The odds of a continued upward trend are 85%.

COPY moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COPY crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +0.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where COPY advanced for three days, in 113 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 21 of 29 cases where COPY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COPY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

COPY broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for COPY entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
a Summary for GM with price predictions
Nov 03, 2026

GM in upward trend: price rose above 50-day moving average on October 29, 2026

GM moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on GM as a result. In 69 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for GM just turned positive on October 28, 2026. Looking at past instances where GM's MACD turned positive, the stock continued to rise in 34 of 50 cases over the following month. The odds of a continued upward trend are 68%.

Following a +4.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where GM advanced for three days, in 236 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

GM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for GM moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 30 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

The Aroon Indicator for GM entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 22 (best 1 - 100 worst), indicating outstanding price growth. GM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.250) is normal, around the industry mean (2.008). P/E Ratio (38.409) is within average values for comparable stocks, (14.609). Projected Growth (PEG Ratio) (0.283) is also within normal values, averaging (2.450). Dividend Yield (0.008) settles around the average of (0.141) among similar stocks. P/S Ratio (0.426) is also within normal values, averaging (2.648).

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
GM: Fundamental Ratings
GM
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
22
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COPYGM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 17 days ago
70%
Bearish Trend 15 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
11%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement

COPY and

Correlation & Price change

A.I.dvisor indicates that over the last year, COPY has been loosely correlated with SAN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if COPY jumps, then SAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COPY
1D Price
Change %
COPY100%
-0.44%
SAN - COPY
59%
Loosely correlated
-1.05%
BMO - COPY
57%
Loosely correlated
-0.80%
ALLY - COPY
52%
Loosely correlated
-1.79%
FITB - COPY
51%
Loosely correlated
-1.89%
GM - COPY
50%
Loosely correlated
-1.78%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XLO8.680.66
+8.23%
Xilio Therapeutics Inc.
XERS10.350.18
+1.77%
Xeris Biopharma Holdings
ROMA6.54N/A
N/A
Roma Green Finance Limited
NTRSO17.39-0.18
-1.02%
Northern Trust Corp
ATR142.31-1.55
-1.08%
AptarGroup